Tumor and Organ Dose Estimates from 177Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial

Zachary Ells, Catherine Meyer, Karam Masri, Marc Ryhiner, David Sennung, Koichiro Kimura, David Mirando, Izabela Tworowska, Rouzbeh Esfandiari, Martin S Allen-Auerbach, Michael Lassmann, Ken Herrmann · 2026

Read Tumor and Organ Dose Estimates from 177Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial by Zachary Ells, Catherine Meyer, Karam Masri, Marc Ryhiner, David Sennung, Koichiro Kimura, David Mirando, Izabela Tworowska, Rouzbeh Esfandiari, Martin S Allen-Auerbach, Michael Lassmann, Ken Herrmann (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13635081.txt.

Description

Zachary Ells and colleagues measured how much radiation tumors and healthy organs absorb during a targeted prostate cancer therapy. Their data come from a randomized phase 2 trial comparing two doses of a lutetium-labeled drug homing to prostate cancer cells. Forty-eight patients had complete imaging sets. The team combined repeated whole-body scans with one detailed three-dimensional scan after the first cycle building dose estimates for kidneys, salivary glands, liver, and tumors.

Healthy organ doses per unit injected were low and did not differ between the two dose sizes. Bone tumors, the commonest site, absorbed moderate doses, varying widely between lesions. Lymph node tumors absorbed more on average in the lower-dose group, a quirk of small numbers. Deeper marker responses tracked with tumor dose in a direction the team reports carefully. The work shows routine imaging can yield patient-specific dose maps for this therapy.

Catalog record

CREATORZachary Ells, Catherine Meyer, Karam Masri, Marc Ryhiner, David Sennung, Koichiro Kimura, David Mirando, Izabela Tworowska, Rouzbeh Esfandiari, Martin S Allen-Auerbach, Michael Lassmann, Ken Herrmann
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13635081

Browse the full library · About the Tower of Babel